Unresectable pancreatic cancer, with a bleak 5-year survival rate of 13.3%, has prompted a shift from traditional surgical interventions to innovative minimally invasive techniques. Researchers detail the evolution from open surgeries to procedures like endoscopic stent placement and percutaneous biliary drainage, improving patient quality of life. Advances such as lumen-apposing metal stents are facilitating key palliative solutions for managing complications like obstructive jaundice and gastric outlet obstruction, offering new hope in this aggressive disease landscape.
Review by Masood M, Irani S (…) Kozarek RA et 3 al. in J Clin Med